News

NASDAQ HCP opened at $34.78 on Friday. The stock has a market cap of $7.11 billion, a PE ratio of -57.02 and a beta of 1.18. HashiCorp has a 12 month low of $23.91 and a 12 month high of $34.85 ...
10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Salem Media Group, Inc operates as a multimedia company in the United States ...
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before. About 30% of Big Pharma ...
BofA analyst Rafe Jadrosich lowered the firm’s price target on D.R. Horton (DHI) to $125 from $150 and keeps a Neutral rating on the shares.The firm is lowering its price targets for ...
In this article, we are going to take a look at where Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) stands against other best pharma stocks to buy for long term growth. With big American ...
Xenon's lead asset, azetukalner, shows promise in treating focal onset seizures with positive phase IIb results and upcoming phase III data expected by end of 2025. Azetukalner's unique Kv7 ...
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before. About 30% of Big Pharma ...
Alter Domus has added to its key client partnerships (KCP) team, appointing Kenny King and Jane Karczewski in two senior roles. King joins as head of KCP for North America from BNY Asset Servicing, ...
Lenard A. Adler has disclosed the following relevant financial relationships: research grants from Takeda and Otsuka Pharmaceuticals; consultant for Bracket/Signant, Supernus Pharmaceuticals ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...